AXXE is in Our Spotlight for Tomorrow
Axxess Pharma Inc.
2681 Eglinton Ave West
Toronto, Ontario
Canada M6M-1T8
Phone: (416) 410-6006
axxesspharmainc.com
PROFILE:
Axxess Pharma: a focused healthcare company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide.
We believe action defines leadership.
Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.
Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE.
VALUE PROPOSITION:
Axxess Pharma Inc. Overview
Axxess Pharma Inc. poised for immediate revenue:
- Goals - to reach 36 million year 4
- Product mass retail across North America
- Worldwide online sales distribution
World-wide exclusive license with TapouT® brand
- World leading athletic lifestyle brand - 350MM/yr
Management: Proven track record, highly experienced
Product Overview
Axxess has a wide range of specialized healthcare products. Products will be launched based on priority and market demand.
Specialized products include:
- Specialized vitamins
- All natural pain relief
- Diabetes-specific supplements
- Pain relief supplements
- Hot/cold therapy
2013 - 2015 Forecast - All Products (000’s)
Growth Plan
Products will distributed in mass retail across the following regions:
- Canada - Currently in market
- USA - Fall of 2014
- Mexico - Fall of 2015
Target mass retailers to include: Walmart, Shoppers Drug Mart, CVS, Rexall, Walgreens, Pharmacia del la oro.
Online Sales to include: Google.com, TapouT.com, UFC.com, Amazon.com
Investment Opportunity
- Private placement offering: 1MM
- Current share price: 0.851
- Discount: 65%
- Current private placement offering: 0.30/share plus bonus warrant
- Discount due to one-year stock restriction
|
|
Pink Sheets: AXXE
Market Value:
33,200,884 a/o Jul 11, 2013
Shares Outstanding:
39,059,863 a/o Mar 31, 2013
Short Interest:
1 (0%)
Jun 28, 2013
Transfer Agent:
Corporate Stock Transfer, Inc.
RECENT NEWS:
Axxess Pharma, Inc. Announces Key Addition to Management with Appointment of Senior Vice President of Sales & Marketing
Axxess Pharma Inc. Receives Upgraded Listing on OTCMarkets.com
KEY EXECUTIVES:
Daniel Bagi, M.D.
President
Mr. Neil Mellor
Senior Vice President
Sales & Marketing
Stephen Taylor
Investor/Business Relations
CEO/Pres. of Taylor Capitol, Inc.
|
